Abstract: Azadirachta indica cell suspension culture is used to metabolize dianabol to yield potent anticarcinogenic 17?-hydroxy-17?-methyl-5?-androst-1-en-3-one, which can also be synthesized.
Type:
Application
Filed:
July 17, 2011
Publication date:
January 17, 2013
Applicant:
HEJ Research Institute of Chemistry
Inventors:
Saifullah, Saifullah Khan, Azizuddin, Muhammad Kashif, Ahsana Dar, Muhammad Iqbal Choudhary
Abstract: Seven new and one known metabolites of tibolone were obtained by incubation of tibolone with various fungi. Their structures were elucidated by means of a homo and heteronuclear 2D NMR and by HREI-MS techniques. The relative stereochemistry was deduced by 2D NOESY experiment. These metabolites of tibolone were strong inhibitors of tyrosine enzyme and thus useful in producing skin lightning and preserving fruits and vegetables.
Type:
Application
Filed:
November 23, 2007
Publication date:
May 28, 2009
Applicant:
HEJ Research Institute
Inventors:
Attaur Rahman, Muhammad Iqbal Choudhary, Syed Adnan Ali Shah, Mahmud Tareq Hassan Khan
Abstract: This invention is directed to a novel method for the inhibition of ?-glucosidase enzyme and thus treating diabetes, viral infections, fungal infections, autoimmune function disorders and obesity using compounds derived as lichen metabolites; more specifically, this includes the therapeutic applications of methylorsellinate (2,4-dihydroxy-6-methylbenzoate, Compound I), methyl-?-orinolcarboxylate (2,4-dihydroxy-3,6-dimethylbenzoate, Compound II) and zeorin (6,22-hopanediol, Compound III).
Type:
Application
Filed:
June 22, 2007
Publication date:
December 25, 2008
Applicants:
Department of Chemistry, University of Peradeniya, HEJ Research Institute
Inventors:
Vinitha Moolchand Thadani, Veranja Karunaratne, Muhammad Iqbal Choudhary
Abstract: A new ent-kaurane type diterpene glucoside, pulicarside (1) was isolated from Pulicaria undulate with a strong ?-glucosidase promoter activity; a large number of clinical applications are provided.
Type:
Application
Filed:
June 7, 2006
Publication date:
November 6, 2008
Applicant:
HEJ Research Institute
Inventors:
Viqar Uddin Ahmad, Muhammad Iqal Choudhary, Nasir Khan, Shamsun Nihar Khan
Abstract: This invention is directed to a novel method for the treatment of diabetes mellitus (Type I, Impaired Glucose Tolerance [“IGT”] and Type II) by administering a therapeutically effective amount of one or both ?-glucosidase inhibitor namely paniculoside IV and ent-16, 17-dihydroxy-(?)-kauran-19-oic acid to humans and animals.